| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Jacob D. Cohen is Chief Executive Officer at MGRX. Jacob D. Cohen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $720K at current prices.
Net of sales, the MGRX filings show accumulation of 275,000 shares.
Jacob D. Cohen has 9 Form 4 filings on record from April 2023 to March 2026, all as Chief Executive Officer at Mangoceuticals (MGRX), 2023–2026.
The 27 reported transactions were 10 gifts, 7 option or other derivative awards, 5 stock awards and 3 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $275K and no sales.
The only open-market purchase was 275,000 shares of MGRX at an average $1.00 on April 10, 2023, about $275K. Twelve months later MGRX was down 69%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2023 | MGRX Mangoceuticals, Inc. | Chief Executive Officer | Buy | 275,000 | $1.00 | $275,000.00 | +3.4% | +91.3% | -69.3% |